Journal of Clinical Virology
Volume 46, Issue 4 , Pages 345-348 , December 2009

Management of varicella contacts in pregnancy: VZIG or vaccination?

  • Judith A. Troughton

      Affiliations

    • Regional Virus Laboratory, Royal Group Hospitals Trust, Belfast BT12 6BN, Northern Ireland, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 2890 634117; fax: +44 2890 311416.
  • ,
  • Grainne Crealey

      Affiliations

    • Clinical Research Support Centre, Royal Group Hospitals Trust, Grosvenor Road, Belfast BT12 6BA, Northern Ireland, United Kingdom
  • ,
  • Vivienne Crawford

      Affiliations

    • School of Medicine & Dentistry, Whitla Medical Building, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, United Kingdom
  • ,
  • Peter V. Coyle

      Affiliations

    • Regional Virus Laboratory, Royal Group Hospitals Trust, Belfast BT12 6BN, Northern Ireland, United Kingdom

Received 10 August 2009 ,Revised 24 August 2009 ,Accepted 10 September 2009.

References 

  1. Enders G, Miller E. Varicella and herpes zoster in pregnancy and the newborn. In:  Arvin AM,  Gershon AA editor. Varicella-zoster virus: virology and clinical management. Cambridge: Cambridge University Press; 2000;p. 317–347
  2. Fairley CK, Miller E. Varicella-zoster virus epidemiology—a changing scene?. J Infect Dis. 1996;174(Suppl. 3):S314–S319
  3. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994;343:1548–1551
  4. Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet. 1989;2:371–373
  5. Department of Health . Screening for infectious disease in pregnancy: standards to support the UK antenatal screening programme. Department of Health; 2003;Crown
  6. Department of Health . Varicella. In:  Salisbury D,  Ramsey M,  Noakes K editor. Immunisation against infectious diseases. London: The Stationary Office; 2006;p. 421–442
  7. Evans EB, Pollock TM, Cradock-Watson JE, Ridehalgh MK. Human anti-chickenpox immunoglobulin in the prevention of chickenpox. Lancet. 1980;1:354–356
  8. Hanngren K, Grandien M, Granstrom G. Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis. 1985;17:343–347
  9. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996;45:1–36
  10. Health Protection Agency (HPA) . Immunoglobulin handbook. Health Protection Agency (HPA); 2007;11-1-0007
  11. Warden J. UK blood products are banned. BMJ. 1998;316:723
  12. Human varicella-zoster immunoglubulin. ABPI electronic medicines compendium. BMJ Publishing Group; 2006;
  13. Varicella Zoster Immune Globulin (VZIG)—anticipated short supply and alternate product availability under an investigational new drug application expanded access protocol. US Food and Drug Administration Center for Biologics Evaluation and Research; 2006;
  14. McKendrick MW, Lau J, Alston S, Bremner J. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention. J Infect. 2007;55:64–67
  15. Pinot dM , Edmunds WJ, Breuer J. The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles. Vaccine. 2006;24:1298–1307
  16. Glantz JC, Mushlin AI. Cost-effectiveness of routine antenatal varicella screening. Obstet Gynecol. 1998;91:519–528
  17. Births in Northern Ireland. Northern Ireland Statistics and Research Agency, National Statistics Publication; 2006;15-3-2007
  18. Coyle PV, McCaughey C, Wyatt DE, O’Neill HJ. Varicella vaccine in pregnancy. Testing should be offered to women without a history of chickenpox. BMJ. 1997;314:226
  19. British National Formulary. BMJ Publishing Group Ltd. and RPS Publishing; 2007;
  20. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–40
  21. Nathwani D, Maclean A, Conway S, Carrington D. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect. 1998;36(Suppl. 1):59–71
  22. Smego RA, Asperilla MO. Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol. 1991;78:1112–1116
  23. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125:651–669
  24. JCVI. Varicella. Minutes of the meeting held on Wednesday 21 June 2006; 2006.

PII: S1386-6532(09)00430-2

doi: 10.1016/j.jcv.2009.09.014

Journal of Clinical Virology
Volume 46, Issue 4 , Pages 345-348 , December 2009